Healthxchange Appointed UK and Ireland Distributor for Jeisys POTENZA

Leading Aesthetics distributor, Healthxchange, has been appointed the new UK and Ireland distributor for the Jeisys POTENZA Advanced Multi-Modality RF Microneedling System, further expanding its energy-based device portfolio and strengthening its position within the advanced aesthetic technologies market.

The POTENZA platform combines both monopolar and bipolar radiofrequency (RF) with invasive and non-invasive tip technologies, enabling clinicians to customise treatments across multiple skin layers, from the epidermis to deeper dermal structures. Designed to address a broad range of aesthetic indications, the system offers flexibility for practitioners to tailor treatment protocols to individual patient needs.

The addition of POTENZA reinforces Healthxchange’s commitment to providing medical professionals with innovative treatment solutions that support personalised patient care and positive clinical outcomes.

The device features adjustable needle tips ranging from 0.5mm to 4mm, alongside specialised applicators designed to deliver RF energy into deeper tissue layers. Its patented pumping tip technology also enables topical agents to be delivered directly into the dermis while simultaneously creating a thermal coagulative effect, enhancing both treatment efficiency and skin rejuvenation outcomes.

Commenting on the partnership, Jack Curran, CEO of Healthxchange, said: “We are delighted to partner with Jeisys to bring the Potenza platform to the UK and Ireland market. As demand grows for advanced, versatile energy-based technologies, our focus remains on providing clinicians with proven solutions that support personalised treatments and strong patient outcomes.

“Potenza is an important addition to our portfolio and reinforces our commitment to innovation and professional education within the aesthetics sector.”

The appointment marks another significant addition to Healthxchange’s growing portfolio of aesthetic technologies, providing UK and Irish practitioners with access to one of the latest multi-modality RF microneedling platforms supported by the company’s education and clinical training programmes.